Experts call for stronger regulation of digital food marketing to counter the increasing risk for obesity and teens’ ...

A report published in November by KFF, a health information nonprofit that includes KFF Health News, found only 13 states were covering GLP-1s for the treatment of obesity for Medicaid beneficiaries ...

This is the final in a four-part series in honor of Mental Health Awareness Month. Maintaining a healthy weight is often a factor in maintaining good mental health. Dr. Scot Currie and Dr. Matt Newlin ...

Obesity often develops through subtle shifts that fly under the radar. Discover the 8 hidden ways weight gain happens gradually in daily life ...

A cross-sectional study showed that rates of metabolic and bariatric surgery increased by almost 15% from 2021 to 2023 among ...

GLP-1 receptor agonists may reduce risk for obesity-related cancers among people with diabetes compared with dipeptidyl ...

Hundreds of thousands of people around the world are now on weight loss drugs like Wegovy, known as GLP-1s. The food industry is taking notice too, with big companies leaning into more nutritional ...

Weightwatchers and bariatric surgery had limited effects on the obese brain, but GLP-1s like Ozempic may mean new hope in ...

Final overall survival (OS) results from the INAVO120 trial (NCT04191499) confirmed that the addition of inavolisib (Itovebi) ...

Research shows intentional weight loss in older adults can lead to better mobility, reduced medical complications, and ...

Obesity causes temporary disruptions, but not permanent structural changes, in the liver’s molecular network that regulates ...

Wegovy belongs to a pricey class of drugs called GLP-1s (short for glucagon-like peptide-1 agonists) that have upended the treatment of obesity in recent years, offering hope to patients who have ...